Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer.
about
Hexaminolevulinate hydrochloride in the detection of nonmuscle invasive cancer of the bladderTime-dependent hexaminolaevulinate induced protoporphyrin IX distribution after topical application in patients with cervical intraepithelial neoplasia: A fluorescence microscopy study.The enhanced anti-cancer effect of hexenyl ester of 5-aminolaevulinic acid photodynamic therapy in adriamycin-resistant compared to non-resistant breast cancer cells.HAL fluorescence cystoscopy and TURB one year of Romanian experience.The role of photodynamic diagnosis in the contemporary management of superficial bladder cancer.5-Aminolevulinic acid derivatives in photomedicine: Characteristics, application and perspectives.Fluorescence diagnosis of bladder cancer.Recent improvements in the detection and treatment of nonmuscle-invasive bladder cancer.Blue-light cystoscopy in the evaluation of non-muscle-invasive bladder cancerHexyl aminolevulinate fluorescence cystoscopy in bladder cancer.Contemporary diagnosis of bladder cancer.Is photodynamic diagnosis ready for introduction in urological clinical practice?Hexaminolevulinate blue light cystoscopy: a review of its use in the diagnosis of bladder cancer.The Impact of Blue Light Cystoscopy on the Diagnosis and Treatment of Bladder Cancer.Fluorescence Imaging for Cancer Screening and Surveillance.Photodynamic therapy with hexyl aminolevulinate induces carbonylation, posttranslational modifications and changed expression of proteins in cell survival and cell death pathways.Photo induced hexylaminolevulinate destruction of rat bladder cells AY-27.Potential role of photodynamic techniques combined with new generation flexible ureterorenoscopes and molecular markers for the management of urothelial carcinoma of the upper urinary tract.A phase-1 study of sequential mitomycin C and 5-aminolaevulinic acid-mediated photodynamic therapy in recurrent superficial bladder carcinoma.Microbiological effect of photodynamic therapy (PDT) in healthy volunteers: a comparative study using methyl aminolaevulinate and hexyl aminolaevulinate cream.Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)?Determination of the bioavailability of [14C]-hexaminolevulinate using accelerator mass spectrometry after intravesical administration to human volunteers.Topical photodynamic therapy using different porphyrin precursors leads to differences in vascular photosensitization and vascular damage in normal mouse skin.In vitrotransdermal and biological evaluation of ALA-loaded poly(N-isopropylacrylamide) and poly(N-isopropylacrylamide-co-acrylic acid) microgels for photodynamic therapy
P2860
Q26775775-7C45AB7E-62DA-4653-A4A7-C5FAEE1253DFQ33208057-C0776784-3D04-4093-A144-8BE675A99325Q34128145-824ACF5E-3A82-4EFF-8A2B-B34A93BA377DQ34480868-17910F6E-9F00-46CC-AD5E-2B3C61018A99Q36166396-47F7604D-20AC-46DF-B2E8-005B6F0F5F6CQ36423131-A73B890F-DB0A-4331-BE61-8F5A16606956Q36533801-CB642F3B-91AA-427C-B621-A593563DFE1AQ36614005-D91B9E63-5719-42C0-AFFB-646C9C55CE54Q37476699-76E5F1DA-AA78-4316-BFCA-13C5B798FBE1Q37577908-81FE0574-BCA7-42BF-ACF9-6E7667225A6CQ38089768-AFA36272-BA47-41DA-BAFF-5562CB7D6508Q38114946-6C0AE347-EDA4-4E08-A84E-E7F1FB9DFF14Q38163897-492EBAAE-DC4E-4F78-AE36-3228BC2B5A5EQ38742159-DEAAAB9A-F216-4506-9425-1016A170BB3FQ39117047-54419A35-8847-4FDE-B91F-31AD099F6F01Q39568538-4C9AB332-B99E-40F9-B252-1DEA3D9DC194Q39572828-103F57C8-5B76-4DBC-B6A2-0C8ED9EACCA9Q40002203-1B5CFF24-94DC-40AD-87E9-E2DE90AD86D2Q46489296-946D145A-3EF7-4470-9662-D2CD956840EDQ46937530-11BDBE76-737A-4B0D-B945-C72E0277360CQ50275555-5873AF83-10E7-4909-B619-CCD30FD87B58Q50480530-4B0FEDFB-B0E3-4F1B-B242-E0D729E56A06Q52648512-8A46857B-B440-44C8-8676-E42F0216BD11Q57371974-BC169728-5DD0-49F6-A42F-4DD7699B57A5
P2860
Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Comparison of aminolevulinic a ...... ution in human bladder cancer.
@en
Comparison of aminolevulinic a ...... ution in human bladder cancer.
@nl
type
label
Comparison of aminolevulinic a ...... ution in human bladder cancer.
@en
Comparison of aminolevulinic a ...... ution in human bladder cancer.
@nl
prefLabel
Comparison of aminolevulinic a ...... ution in human bladder cancer.
@en
Comparison of aminolevulinic a ...... ution in human bladder cancer.
@nl
P2093
P1476
Comparison of aminolevulinic a ...... ution in human bladder cancer.
@en
P2093
H J Leisinger
J-P Ballini
P Jichlinski
P304
P356
10.1097/01.JU.0000075054.38441.2D
P407
P433
P577
2003-08-01T00:00:00Z